Truveta

Join us on September 18th to learn: ✔️ Why researchers are betting on EHR data as the future of real-world evidence generation ✔️ What to look for when evaluating the quality of a real-world dataset. Register now: https://tr.vet/3Z4TehI

Earlier this summer, we invited leaders from healthcare, life sciences, and public health to our Bellevue, Washington HQ for our second annual Truveta Symposium. Guests were able to: 🧑🏫 Share their research and learn about each other's studies using Truveta Data, 🧠 Brainstorm shared research interests and potential collaboration opportunities, and 🍿 Preview exciting new Truveta Studio features and functionalities. Big thank you to all of our creative, passionate guests at this year's Truveta Symposium. We can't wait to see you again next year.

Today we announced our new partnership with The CHOICE Institute at the University of Washington to drive comparative, cost-effectiveness, and outcomes research across a wide range of therapeutic areas. With access to Truveta's real-world EHR data, the CHOICE team will explore critical conditions like diabetes, dementia, and cystic fibrosis, among others. We are excited to partner with this innovative academic research organization toward a shared mission of Saving Lives with Data: https://tr.vet/47cvQRs

In his latest article, Jay Nanduri, Truveta co-founder and CTO, explores how we're ensuring our AI solutions meet the highest standards of privacy, security, regulatory-grade operations, and ethics. Curious about how to make healthcare data available for clinical and life science research while leveraging AI in a safe and compliant manner? Find out: https://lnkd.in/gD7E95sZ

Used to treat inflammatory conditions like arthritis, psoriasis, and Crohn's disease, biologic medication #Humira is the highest-grossing medication in history. But, its 20-year market exclusivity ended in 2023, and now more than 10 biosimilars have been approved in the US. But despite lower prices, sales data on biosimilars have shown low uptake. To encourage switching, CVS Pharmacy removed Humira from some formularies in favor of one of the less expensive biosimilars. Truveta Research examined whether uptake of biosimilars has increased since CVS's shift. Learn more: https://tr.vet/46CGAZ9 #InflammatoryConditions #Arthritis #CrohnsDisease #Psoriasis #DrugCosts #PrescriptionCosts #PrescriptionTrends #Biologic #Biosimilar #HealthData #HealthcareData #HealthInnovation #HealthAI #HealthcareInnovation #HealthcareData #AI #Innovation #MedicalTechnology #MedTech #MedicalData #MedicalAI #MedicalInnovation

That’s a wrap on #ISPEAnnual2024! Thanks to Principal Applied Research Scientist Duy Do for representing Truveta. Explore the research: Removing race from CKD diagnostic criteria: https://tr.vet/4e2tNBH GLP-1 switching trends: https://tr.vet/4dwWNBy

Download our whitepaper on #DataQuality to learn: 🧼 How healthcare data from our member health systems is securely stored, cleaned, and de-identified for use in Truveta Studio, 📏 Our approach to measuring data quality along dimensions including representativeness, completeness, timeliness, and cleanliness, and 📨 Our quality processes and systems in place to support regulatory submissions using Truveta Data. https://tr.vet/3yYLOBY #Whitepaper #HealthWhitepaper #HealthcareWhitepaper #MedicalWhitepaper #DataWhitepaper #HealthData #HealthcareData #MedicalData #RegulatoryGrade #RegGrade #RegulatorySubmission #HealthAI #HealthInnovation #AI #Innovation #HealthcareAI #HealthcareInnovation #MedicalAI #MedicalInnovation

Watch Stanford University Resident Physician Jimmy Zheng, MD, MS, explain a recent study he performed using Truveta Data to evaluate how heart failure is treated in the real world across various clinics and patients in the United States - and how, surprisingly, very little has changed in HF treatment in the past decade. #HeartFailure #HeartFailureTreatment #HeartFailureResearch #CardiovascularResearch #RealWorldData #RealWorldEvidence #HealthData #HealthcareData #HealthTech #HealthcareTech #HealthAI #HealthInnovation #HealthcareAI #HealthcareInnovation #AI #Innovation #MedicalData #MedicalTechnology #MedTech #MedicalAI #MedicalInnovation #MedicalResearch #HealthResearch #HealthcareResearch

Now available to review within Truveta Studio: Truveta Research's recent study on how occurrences, prescriptions, and outcomes related to chronic kidney disease shifted following the implementation of a race-free CKD-EPI creatinine equation used for diagnoses in 2021, compared with the race-inclusive CKD-EPI creatinine equation used previously. Use your LinkedIn credentials to log in and view the study now: https://tr.vet/3AHC2ES #ISPEAnnual2024 #ISPEAnnualMeeting #ISPEAnnualMeeting2024 #ICPE #ICPEAnnual2024 #ICPEAnnualMeeting2024 #ISPE #Pharmacoepidemiology #Berlin #ChronicKidneyDisease #CKD #KidneyDisease #Creatinine #CreatinineEquation #CKDEPI #HealthEquity #HealthcareEquity #SDOH #SocialDriversOfHealth #SocialDeterminantsOfHealth #PrescriptionTrends #GLP1s #HealthData #HealthcareData #HealthcareAI #HealthAI #AI #Innovation #HealthInnovation #HealthcareInnovation #MedicalData #MedicalAI #MedicalInnovation #MedicalTechnology #MedTech #EHRData #ElectronicHealthRecords

In 2019, the US government unveiled the ambitious Ending the HIV Epidemic plan, aiming to slash new HIV infections by 90% by 2030. To meet this goal, research into HIV, its causes, and its treatments, must accelerate. Watch this video to learn how we're supporting HIV research, and learn more here: https://tr.vet/3LLL9qq